MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $698,500 | -91.9% | 550,000 | -79.1% | 0.09% | -89.1% |
Q2 2023 | $8,662,241 | -44.5% | 2,632,900 | -30.7% | 0.86% | -56.8% |
Q1 2023 | $15,618,000 | -33.3% | 3,800,000 | -4.9% | 2.00% | -28.4% |
Q4 2022 | $23,422,479 | -13.3% | 3,997,010 | 0.0% | 2.79% | -8.7% |
Q3 2022 | $27,020,000 | +36.0% | 3,997,010 | -7.0% | 3.05% | +52.8% |
Q2 2022 | $19,863,000 | +15.8% | 4,299,297 | 0.0% | 2.00% | +23.3% |
Q1 2022 | $17,154,000 | -35.9% | 4,299,297 | 0.0% | 1.62% | -30.0% |
Q4 2021 | $26,742,000 | -34.0% | 4,299,297 | 0.0% | 2.32% | -27.2% |
Q3 2021 | $40,542,000 | -25.5% | 4,299,297 | +7.3% | 3.18% | -26.4% |
Q2 2021 | $54,396,000 | -16.1% | 4,005,600 | 0.0% | 4.32% | -30.4% |
Q1 2021 | $64,810,000 | -16.8% | 4,005,600 | +36.9% | 6.21% | -21.9% |
Q4 2020 | $77,887,000 | +47.4% | 2,927,000 | +3.2% | 7.95% | +27.8% |
Q3 2020 | $52,824,000 | -12.2% | 2,837,000 | +10.4% | 6.22% | -7.0% |
Q2 2020 | $60,138,000 | +175.1% | 2,570,000 | -31.5% | 6.69% | +139.9% |
Q1 2020 | $21,862,000 | +1.7% | 3,750,000 | 0.0% | 2.79% | +56.4% |
Q4 2019 | $21,487,000 | +262.6% | 3,750,000 | 0.0% | 1.78% | +140.0% |
Q3 2019 | $5,925,000 | -61.0% | 3,750,000 | 0.0% | 0.74% | -60.8% |
Q2 2019 | $15,187,000 | -23.0% | 3,750,000 | 0.0% | 1.89% | -36.3% |
Q1 2019 | $19,725,000 | – | 3,750,000 | – | 2.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |